TELL ME MORE ABOUT THIS STUDY
This is a safety and efficacy study for Adults with Moderate to Severe Hidradenitis Suppurativa (Hurley Stage II or III)
Enrolling Adults 18+ years in Evansville, IN
[contact-form-7 id=”1370″ title=”Study Contact Form – Hidradenitis Suppurativa”]
Hidradenitis suppurativa is a chronic condition that occurs when hair follicles in the skin become blocked. The exact cause is unknown, but it is not caused by infection or uncleanliness. It cannot be spread to other people by contact. The condition causes red, painful bumps that may break open or form tunnels under the skin. Scarring is common. The condition usually presents after puberty and forms in areas where skin rubs together such as armpits, buttocks, breasts, and the groin. Hidradenitis suppurativa is an inflammatory condition that can persist for many years and interfere with quality of life. Medications and surgery can help manage symptoms and prevent complications.
View More Studies
| Condition | Location | Status | Age Range | Sex | Max Compensation | |
|---|---|---|---|---|---|---|
| ADHD A Long-term study Evaluating the Safety of an Investigational Medication Administered with a Psychostimulant in children with ADHD | Evansville | Enrolling | 6 - 17 | $1500 | Request Info | |
| ADHD A placebo controlled study evaluating the Efficacy and Safety of an Investigational Medication for Children with ADHD | Bowling Green Evansville Owensboro | Enrolling | 4-12 | $416-$1040 | Request Info | |
| COPD A Phase 3 Study to Evaluate the Efficacy and Safety of Two Dose Regimens of an Investigational Medication in Participants with Symptomatic COPD | Bowling Green | Enrolling | 40+ | Up to $1200 | Request Info | |
| COPD Safety, Efficacy and Tolerance study for moderate to severe COPD | Owensboro | Enrolling | 40-85 | Up to $750 | Request Info | |
| DIABETES (T2DM) Safety and Efficacy of an Investigational Medicine for pediatric and adolescent patients with type 2 diabetes. | Evansville | Enrollin | 10-17 | Up to $875 | Request Info | |
| DIABETES (T2DM) Study to Evaluate the Efficacy and Safety of an Investigation Medication as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults with Type 2 Diabetes | Bowling Green Evansville Owensboro | Enrolling | 18 Years & Up | $1625 | Request Info | |
| DIABETES (T2DM) Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared with Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes | Bowling Green Evansville Owensboro | Enrolling | 18 Years & Up | Up to $3125 | Request Info | |
| ECZEMA (Atopic Dermatitis) Safety and efficacy, placebo-controlled study of a topical investigational medicine with open-label extension in patients with moderate to severe eczema | Owensboro Evansville | Enrolling | 2-17 Years Old | $1470 | Request Info | |
| ECZEMA (Atopic Dermatitis) Safety and efficacy, placebo-controlled study of a topical investigational medicine in patients with moderate to severe eczema | Evansville Bowling Green | Enrolling | 2+ (child through adult) | $975 | Request Info | |
| Obesity A Study Evaluating the Efficacy of an Investigational Medication in Adults with Obesity | Evansville | Enrolling | 40+ | $1530 | Request Info | |
| INFANT FORMULA & BREASTFEEDING Infant Formula for Healthy Babies | Evansville Owensboro | Enrolling | Newborns | $625 + formula | Request Info | |
| LUPUS (SLE) A Randomized, Placebo-Controlled Clinical Trial for the Treatment of Systemic Lupus Erythematosus | Evansville | Enrolling | 18 - 65 | $1350 | Request Info | |
| LUPUS NEPHRITIS A Safety, efficacy and tolerability study for patients with active Lupus Nephritis | Evansville | Enrolling | 18 - 75 | $4625 ($125 per visit) | Request Info | |
| MIGRAINES in CHILDREN A Double Blind, Placebo Controlled Study of an Investigational Medicine for Pediatric Migraines | BowlingGreen Owensboro Evansville | Enrolling | 6 - 17 | $200/$350 | Request Info | |
| MENINGOCOCCAL VACCINE Safety and Immunogenicity of a Meningococcal B vaccine when Administered Together with the MENVEO (MenACWY) Vaccine in healthy subjects age 16 - 18 | Evansville | Enrolling | 16-18 | $300 | Request Info | |
| PSORIASIS A Double-blind, Placebo-controlled Study to Investigate the Efficacy of an Investigational Oral Medication of Moderate to Severe Plaque Psoriasis | Owensboro Evansville | Enrolling | 18-75 | Up to $585 | Request Info | |